The contemporary surgical management of spasticity in children

Physical Medicine and Rehabilitation Clinics of North America

Volumn 12, Issue 4, 2001, Pages 907-922

  Grabb, P A ^a   Doyle, J S ^a  

^a CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN;

CHILD; CONSERVATIVE TREATMENT; DORSAL RHIZOTOMY; EVALUATION; HEMATOMA; HUMAN; LUNG DISEASE; MUSCLE EXCITATION; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SPASTICITY; SURGICAL APPROACH; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0035149417     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1047-9651(18)30038-x     Document Type: Review

References (54)

1. Complications with selective posterior rhizotomy
2. Plasma baclofen levels in children receiving continuous intrathecal baclofen infusion
3. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy
4. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin
5. Brachial plexus dorsal rhizotomy in the treatment of upper-limb spasticity
6. One session surgery for the correction of lower limb deformities in spastic diplegia
7. Developmental skills of children with spastic diplegia: Functional and qualitative changes after selective dorsal rhizotomy
8. Orthopedic procedures after rhizotomy
9. Selective dorsal rhizotomy and rates of orthopedic surgery in children with spastic cerebral palsy
10. Hip dislocation in spastic cerebral palsy: Long term consequences
11. Growth induced by incremental static stretch in adult rabbit latissimus dorsi muscle
12. Factors associated with contractures in acute spinal cord injury
13. Quantitative assessment of intrathecally administered baclofen in spasticity
14. Changes in ankle spasticity and strength following selective dorsal rhizotomy and physical therapy for spastic cerebral palsy
15. Spasticity and strength changes as a function of selective dorsal rhizotomy
16. Rectus femoris transfer to improve knee function of children with cerebral palsy
17. Kinematic and dynamic analysis of the ankle joint in children with cerebral palsy
18. Effect on ambulation of continuous intrathecal baclofen infusion
19. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy
20. Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial
21. Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity
22. Long-term outcome after selective posterior rhizotomy in children with spastic cerebral palsy
23. Bladder function before and after selective dorsal rhizotomy in children with cerebral palsy
24. Cerebral palsy: Management of the upper extremity
25. Common abnormal kinetic patterns of the knee in gait in spastic diplegia of cerebral palsy
26. Upper extremity performance and self-care skill changes in children with spastic cerebral palsy following selective posterior rhizotomy
27. A comparison of continuous epidural infusion and intermittent intravenous bolus doses of morphine in children undergoing selective dorsal rhizotomy
28. Selective dosal rhizotomy: Efficacy and safety in an investigator-masked randomized clinical trial
29. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: A preliminary report
30. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-Year experience
31. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy
32. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity
33. Physiology of soft tissue surgery
34. 4.5 Year follow-up after surgical correction of upper extremity deformities in spastic cerebral palsy
35. Lack of specificity in electrophysiological identification of lower sacral roots during selective dorsal rhizotomy
36. Selective lumbosacral dorsal rhizotomy immediately caudal to the conus medullaris for cerebral palsy spasticity
37. Distal rectus femoris transfer
38. Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: Long-term follow-up review of 18 patients
39. Functional changes in the antagonists after lengthening the agonists in cerebral palsy: I
40. Functional changes in the antagonists after lengthening the agonists in cerebral palsy: II
41. Cerebral palsy
42. Neuromuscular electrical stimulation and dynamic bracing as a treatment for upper-extremity spasticity in children with cerebral palsy
43. Anterior hip dislocation in children with cerebral palsy
44. Surgical prophylaxis of subluxation and dislocation of the hip in cerebral palsy
45. Current concepts review: Management of the upper extremity in cerebral palsy
46. The validity of electrophysiological criteria used in selective functional posterior rhizotomy for treatment of spastic cerebral palsy
47. Complications after posterior selective rhizotomy for spasticity in children with cerebral palsy
48. Gait before and 10 years after rhizotomy in children with cerebral palsy
49. Does gait continue to improve 2 years after selective dorsal rhizotomy?
50. The risk of spinal deformity after selective dorsal rhizotomy
51. Intrathecal baclofen for intractable cerebral spasticity: A prospective placebo-controlled, double-blind study
52. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: A randomized controlled trial
53. Muscle growth in normal and spastic mice